Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anna Schölin"'
Autor:
Anna Schölin, E. Björk, Christian Berne, F. A. Karlsson, Hans J. Arnqvist, Lennarth Nyström, Jan Bolinder
Publikováno v:
Diabetic Medicine. 28:156-161
Aims After initiation of treatment in Type 1 diabetes, a period with lower insulin requirement often follows, reflecting increased insulin sensitivity and improved insulin secretion. We explored if ...
Autor:
Anna Schölin, J Ostman, Carina Törn, Göran Sundkvist, Lennarth Nyström, Jan Bolinder, Jan W. Eriksson, Hans J. Arnqvist, Elisabeth Björk, F A Karlsson, G Blohmé, Ingrid Kockum, C Berne, Mona Landin-Olsson
Publikováno v:
Diabetic Medicine. 21:447-455
Aim To identify clinical, immunological and biochemical factors that predict remission, and its duration in a large cohort of young adults with Type 1 diabetes mellitus (DM). Methods In Sweden 362 patients (15-34 years) classified as Type 1 DM were,,
Autor:
Göran Sundkvist, Anna Schölin, Jan Bolinder, Göran Blohmé, Lennarth Nyström, Elisabeth Björk, Marianne Henricsson, Carin E. Kullberg, Hans J. Arnqvist, Maria Svensson, Jan W. Eriksson, Jan Östman
Publikováno v:
Diabetes Care. 26:349-354
OBJECTIVE—To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden. RESEARCH DESIGN AND METHODS—The Diabetes Incidence S
Publikováno v:
Journal of Internal Medicine. 245:155-162
To describe the course of clinical remission in adult patients (16-50 years of age) with type 1 diabetes and to identify factors predictive of the occurrence and length of remission.A retrospective cohort study.Sixty-two consecutive patients (43 men
Autor:
Göran Sundkvist, Bengt Littorin, S Gudbjornsdottir, G Blohmé, Anna Schölin, Jan W. Eriksson, J Ostman, Annika Ekbom-Schnell, P. Blom, Lennarth Nyström, Jan Bolinder, Hans J. Arnqvist
Publikováno v:
Diabetologia. 49(12)
Low plasma vitamin D concentrations may promote the development of type 1 diabetes. To test this hypothesis, we measured plasma 25-hydroxyvitamin D (25OHD) in young adults with type 1 diabetes.The nationwide Diabetes Incidence Study in Sweden (DISS)
Autor:
Göran Sundkvist, C Berne, F. Anders Karlsson, Agneta Siegbahn, Lars Lind, Elisabeth Björk, Anna Schölin
Publikováno v:
Diabetes/metabolism research and reviews. 20(3)
The role of non-specific inflammation in beta-cell loss in type 1 diabetes is unclear. In the present study, inflammatory markers were determined in patients with newly diagnosed disease and related to beta-cell function, glycemic control and autoimm
Autor:
Henrik Borg, Ostman J, Lars J. Björklund, Lennarth Nyström, Anders F Karlsson, Anna Schölin, Hans J. Arnqvist, G Blohmé, Elisabeth Björk, S Gudbjornsdottir, Jan W. Eriksson, Göran Sundkvist, Jan Bolinder
Publikováno v:
Journal of Internal Medicine; 255(3), pp 384-391 (2004)
Objectives. To establish the prevalence of remaining beta-cell function 8 years after diagnosis of diabetes in young adults and relate the findings to islet antibodies at diagnosis and 8 years later. Design. Population-based cohort study. Setting. Na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e07af1b3e72952cdc7b786c58e79f113
http://lup.lub.lu.se/record/120623/file/623956.pdf
http://lup.lub.lu.se/record/120623/file/623956.pdf
Autor:
Marianne, Henricsson, Lennarth, Nyström, Göran, Blohmé, Jan, Ostman, Carin, Kullberg, Maria, Svensson, Anna, Schölin, Hans J, Arnqvist, Elisabeth, Björk, Jan, Bolinder, Jan W, Eriksson, Göran, Sundkvist
Publikováno v:
Diabetes care. 26(2)
To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden.The Diabetes Incidence Study in Sweden (DISS) aims to register all
Publikováno v:
Upsala journal of medical sciences. 105(2)
Type 1 diabetes is the result of a chronic inflammatory process that causes elimination of insulin-producing beta-cells, resulting in insulin deficiency and hyperglycemia. The destruction is thought to be mediated by an autoimmune process involving c
Autor:
Anna Schölin, Göran Sundkvist
Publikováno v:
Journal of Internal Medicine; 256(3), pp 264-264 (2004)